Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant dataStella G. Muthuri, Elga Mayo-Montero, Bojana Beovič et al.|The Lancet Respiratory Medicine|2014Cited by 648
Mortality and morbidity in community-acquired sepsis in European pediatric intensive care units: a prospective cohort study from the European Childhood Life-threatening Infectious Disease Study (EUCLIDS)Navin P. Boeddha, Marieke Emonts, Luregn J. Schlapbach et al.|Critical Care|2018Cited by 158
The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: A retrospective cases seriesIsabelle Koné‐Paut, Maryam Piram, Rolando Cimaz et al.|Autoimmunity Reviews|2018Cited by 129
Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus InfectionSudhir Venkatesan, Dragan Mikić, Puja Myles et al.|The Journal of Infectious Diseases|2019Cited by 37
Segmental and global longitudinal strain differences between Kawasaki disease and multi-system inflammatory syndrome in childrenEnrico Piccinelli, Giovanni Di Salvo, Carles Bautista-Rodríguez et al.|Cardiology in the Young|2022Cited by 5